MDC — Medlab Clinical Income Statement
0.000.00%
Last trade - 00:00
HealthcareAdventurousMicro Cap
2018 June 30th | 2019 June 30th | 2020 June 30th | R2021 June 30th | 2022 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.55 | 7.8 | 2.92 | 0.758 | 1.33 |
Cost of Revenue | |||||
Gross Profit | 3.53 | 4.65 | 0.086 | 0.706 | 0.974 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 10.2 | 16.2 | 16.7 | 11.2 | 9.7 |
Operating Profit | -4.7 | -8.39 | -13.7 | -10.4 | -8.37 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.76 | -8.17 | -13.5 | -9.63 | -8.39 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.76 | -8.17 | -13.5 | -9.63 | -8.39 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -4.57 | -8.09 | -13.4 | -6.78 | -7.16 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.57 | -8.09 | -13.4 | -6.78 | -7.16 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.58 | -5.81 | -8.9 | -5.12 | -3.65 |
Dividends per Share |